Lucid Diagnostics Inc. — Director's Dealing 2023

Sep 27, 2023

SEC Form 4/A — Form 4/A

Issuer: Lucid Diagnostics Inc. (LUCD)
CIK: 0001799011
Period of Report: 2023-09-20

Reporting Person: Lapidus Stanley (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-09-20	Common stock	S	3405	$1.45	Disposed	132051	Direct
2023-09-20	Common stock	S	412	$1.44	Disposed	131639	Direct
2023-09-21	Common stock	S	100	$1.44	Disposed	131539	Direct

Footnotes

F1: Each sale was in connection with the Reporting Person's estimated income tax withholdings related to vested restricted stock.

F2: Represents shares the Reporting Person received as a restricted stock grant under the Issuer's 2018 Equity Plan. Such grant was 169,320 shares of common stock, 50% of which vested September 20, 2022 and 50% of which vested September 20, 2023.

F3: The reported sales of shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 16, 2023.